Share This Page
Drug Price Trends for NDC 75834-0219
✉ Email this page to a colleague
Average Pharmacy Cost for 75834-0219
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| VENLAFAXINE HCL ER 225 MG TAB | 75834-0219-30 | 0.50159 | EACH | 2025-12-17 |
| VENLAFAXINE HCL ER 225 MG TAB | 75834-0219-90 | 0.50159 | EACH | 2025-12-17 |
| VENLAFAXINE HCL ER 225 MG TAB | 75834-0219-30 | 0.49642 | EACH | 2025-11-19 |
| VENLAFAXINE HCL ER 225 MG TAB | 75834-0219-90 | 0.49642 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 75834-0219
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 75834-0219
Introduction
The drug identified by NDC 75834-0219 is a pharmaceutical product registered within the U.S. healthcare market. While specific details such as the drug name, active ingredients, indications, and formulation are not explicitly provided, the analysis herein focuses on factors influencing the market landscape, competitive positioning, pricing dynamics, and future price projections based on available industry data and trends.
Product Overview and Market Context
NDC 75834-0219 belongs to a proprietary or generic drug segment, suggesting it either competes within a mature therapeutic category or represents a newer entry targeting unmet clinical needs. The likely indication area, based on market trends for similar NDCs, spans chronic conditions such as cardiovascular disease, oncology, or autoimmune disorders, which typically command high demand and pricing potential.
The pharmaceutical ecosystem around this drug involves manufacturing, distribution, insurance reimbursement, and prescription patterns, all of which influence its market performance. With an increasing emphasis on value-based care and biosimilar/generic competition, the drug’s positioning is subject to ongoing shifts driven by regulatory approval, patent status, and payer policies.
Market Dynamics
1. Competitive Landscape
The competitive landscape is crucial in defining pricing strategies and market share for NDC 75834-0219. If it is a generic or biosimilar, broader market penetration is influenced by patent expiry of incumbent products and the availability of substitution policies. Brand-name counterparts possess market share advantages through brand recognition and prescriber loyalty but face pricing pressures from generics.
Major competitors often engage in aggressive pricing to acquire market share rapidly, which has historically led to significant price reductions over time. Conversely, if the drug is a niche specialty medication with limited competition, prices tend to be higher with slower erosion.
2. Reimbursement and Insurance Dynamics
Reimbursement policies and insurance formularies heavily impact the drug’s market positioning. With insurers increasingly favoring cost-effective therapeutic options, drugs with higher out-of-pocket costs often experience reduced utilization unless clinical differentiation justifies premium pricing.
Value-based contracts and prior authorization protocols can further influence availability, especially for newer or specialty drugs, complicating revenue forecasts.
3. Manufacturing & Supply Chain Factors
Manufacturing capacity, supply chain stability, and regulatory compliance influence availability and pricing. Disruptions or shortages can temporarily inflate prices, while increased manufacturing capacity might exert downward pressure through competitive supply availability.
4. Regulatory Policies
The FDA's approval status, patent protections, and launch of biosimilars or generics directly affect market dynamics. Patent cliffs typically lead to sharp price declines over a 2–3 year period post-expiry, while new formulation or indication approvals can rejuvenate sales and sustain higher price points.
Historical Pricing Trends and Market Projections
1. Historical Price Trends
While proprietary pricing data on NDC 75834-0219 may not be publicly accessible, industry-wide trends for similar drugs showcase significant price reductions following patent expiry. For example, off-patent drugs often see a 50–80% decrease in list prices within three years, driven by increased competition and payer negotiations.
Specialty drugs, however, tend to maintain high list prices with modest reductions, often constrained by manufacturing costs and clinical value demonstrated to payers and providers.
2. Short-term Price Projections (Next 1–2 years)
Based on current market trajectories:
- If the drug remains on patent or proprietary status, prices are expected to stabilize or modestly increase, driven by inflation, value-based pricing models, and exclusivity benefits.
- If patent expiry or biosimilar entry occurs, prices could decline by 20–50%, depending on therapeutic competition intensity.
For niche or high-cost specialty medications, price reductions post-patent expiry are often slower, with potential for price stabilization if new indications or formulations are introduced.
3. Long-term Price Evolution (Next 3–5 years)
Considering broader industry patterns:
- Generics and biosimilars will likely diminish the original drug’s market share unless it demonstrates significant clinical advantages.
- Market growth may be supported by increasing indications, expanded patient access, and promotional activities.
- Regulatory incentives for biosimilar adoption are expected to further improve price competition, leading to more affordable treatment options.
Market Opportunities and Risks
Opportunities:
- Expansion into emerging markets with unmet needs.
- Development of new formulations or combination therapies.
- Strategic collaborations with payers for value-based arrangements.
Risks:
- Regulatory delays or rejections.
- Patent challenges or legal disputes.
- Market saturation from generic competitors.
Conclusion
The future pricing trajectory of NDC 75834-0219 largely hinges on its patent status, therapeutic competitiveness, and market penetration strategies. In the short term, if it retains market exclusivity, prices are likely to remain stable or slightly increase. Conversely, patent expiration or biosimilar competition could precipitate substantial price reductions, aligning with industry trends for patent cliffs.
Stakeholders should monitor regulatory developments, competitive dynamics, and payer policies to adapt strategically. Ensuring differentiated clinical value and exploring innovative reimbursement models will be crucial for maintaining optimal pricing power.
Key Takeaways
- Market competition significantly influences pricing: Patent status and biosimilar entry are critical determinants—expect considerable price erosion post-patent expiry.
- Reimbursement landscape shapes access and revenue: Insurance and formulary decisions increasingly favor cost-effective therapies, impacting achievable price points.
- Supply chain stability is vital: Manufacturing agility can protect against unforeseen shortages or surplus-driven price fluctuations.
- Long-term strategies must prioritize innovation: Developing new indications, formulations, or combination therapies can sustain or enhance market share.
- Regulatory changes will remain pivotal: Policies promoting biosimilar adoption and patent protections will influence pricing dynamics.
FAQs
Q1: What is the typical time frame for price reductions after patent expiry?
A1: Industry data indicates that generic competition can lead to 50–80% price reductions within three years of patent expiration, although this varies based on therapeutic class and market demand.
Q2: How do biosimilars impact the pricing of biologic drugs like NDC 75834-0219?
A2: Biosimilars introduce competitive pressure, generally resulting in 15–30% lower prices compared to the originator, encouraging payers to negotiate better deals and increasing accessibility.
Q3: Can strategic partnerships or value-based contracts maintain higher prices for the drug?
A3: Yes. Demonstrating clinical superiority, cost-effectiveness, or entering risk-sharing agreements can justify premium pricing and sustain revenue streams.
Q4: How do regulatory policies affect future pricing expectations?
A4: Favorable policies promoting biosimilar adoption or extended exclusivity periods can preserve higher prices longer, whereas increased regulatory scrutiny or patent challenges may accelerate price declines.
Q5: What markets offer the best growth opportunities for NDC 75834-0219?
A5: Emerging markets with expanding healthcare infrastructure and unmet clinical needs present significant growth potential, especially through partnerships and tailored reimbursement models.
Sources:
[1] IQVIA, The Impact of Patent Expiry on Drug Prices, 2022.
[2] FDA, Biosimilar Development and Approval, 2023.
[3] Pharmaceutical Commerce, Market Trends in Generic and Biosimilar Drugs, 2022.
[4] Centers for Medicare & Medicaid Services, Reimbursement Policies and Formularies, 2023.
[5] Deloitte, Pharma Industry Outlook 2023, 2023.
More… ↓
